The present invention provides a process for preparing compounds of formula (IV), or a pharmaceutically acceptable salt thereof. The compounds prepared by the process of the invention inhibit tyrosine kinase activity of growth factor receptors such as HER1, HER2 and HER4 thereby making them useful as antiproliferative agents for the treatment of cancer and other diseases.
申请公布号
WO2006069395(A2)
申请公布日期
2006.06.29
申请号
WO2005US47630
申请日期
2005.12.21
申请人
BRISTOL-MYERS SQUIBB COMPANY;CHEN, PING;NORRIS, DEREK, J.;GAVAI, ASHVINIKUMAR, V.
发明人
CHEN, PING;NORRIS, DEREK, J.;GAVAI, ASHVINIKUMAR, V.